<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03613493</url>
  </required_header>
  <id_info>
    <org_study_id>20180033</org_study_id>
    <nct_id>NCT03613493</nct_id>
  </id_info>
  <brief_title>Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention</brief_title>
  <official_title>Acceptability of HPV Self-sampling Tools for Cervical Cancer Prevention in Jamaican Women: A Theory-based Approach to Culturally-tailored Message Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study aims to increase HPV screening behaviors in Jamaican women by examining
      the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine
      the most culturally appropriate and effective message design for promoting such a tool in
      this context.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Budgetary and Timing Constraints
  </why_stopped>
  <start_date type="Actual">July 10, 2018</start_date>
  <completion_date type="Actual">October 1, 2018</completion_date>
  <primary_completion_date type="Actual">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants That Used and Returned Their Self-sampler Kit.</measure>
    <time_frame>2 weeks</time_frame>
    <description>Number of participants that used and returned their self-sampler kit was evaluated.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">175</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>HPV self-sampling kit + Interview</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Culturally-targeted Fear appeal message HPV self-sampling kit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fear appeal message HPV self-sampling kit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HPV self-sampling kit</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive an HPV self-sampling kit to screen for HPV</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HPV self-sampling kit</intervention_name>
    <description>The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.</description>
    <arm_group_label>Culturally-targeted Fear appeal message HPV self-sampling kit</arm_group_label>
    <arm_group_label>Fear appeal message HPV self-sampling kit</arm_group_label>
    <arm_group_label>HPV self-sampling kit</arm_group_label>
    <arm_group_label>HPV self-sampling kit + Interview</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Culturally-targeted Fear Appeal Message</intervention_name>
    <description>Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.</description>
    <arm_group_label>Culturally-targeted Fear appeal message HPV self-sampling kit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fear Appeal Message</intervention_name>
    <description>Participants will receive fear appeal messages (only) in a graphically designed kit.</description>
    <arm_group_label>Fear appeal message HPV self-sampling kit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interview</intervention_name>
    <description>Participants will be interviewed about experiences using the self-sampling tool (qualitative).</description>
    <arm_group_label>HPV self-sampling kit + Interview</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Jamaican women, aged 30 to 65.

        Exclusion Criteria:

          -  Women who report having had a hysterectomy,

          -  have had a history of cervical cancer,

          -  Women who are currently up-to-date on cervical cancer screening (have had a Pap in the
             last 3 years or have had a Pap smear/HPV co-test within the past 5 years),

          -  Adults unable to consent, children, pregnant women and prisoners.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan E Morgan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 17, 2018</study_first_submitted>
  <study_first_submitted_qc>August 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <results_first_submitted>July 10, 2019</results_first_submitted>
  <results_first_submitted_qc>July 31, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 2, 2019</results_first_posted>
  <last_update_submitted>July 31, 2019</last_update_submitted>
  <last_update_submitted_qc>July 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Susan Morgan</investigator_full_name>
    <investigator_title>Associate Provost for Research Development and Strategy</investigator_title>
  </responsible_party>
  <keyword>HPV</keyword>
  <keyword>self-sampling</keyword>
  <keyword>culture</keyword>
  <keyword>message design</keyword>
  <keyword>health communication</keyword>
  <keyword>Jamaica</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 27, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03613493/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HPV Self-sampling Kit + Interview</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interview: Participants will be interviewed about experiences using the self-sampling tool (qualitative).</description>
        </group>
        <group group_id="P2">
          <title>Culturally-targeted Fear Appeal Message HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message: Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.</description>
        </group>
        <group group_id="P3">
          <title>Fear Appeal Message HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Fear Appeal Message: Participants will receive fear appeal messages (only) in a graphically designed kit.</description>
        </group>
        <group group_id="P4">
          <title>HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="90"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Enrollment Criteria Met</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="74"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="73"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="83"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Due to budgetary constraints, participants were not enrolled into the Fear Appeal HPV self-sampler kit arm.</population>
      <group_list>
        <group group_id="B1">
          <title>HPV Self-sampling Kit + Interview</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interview: Participants will be interviewed about experiences using the self-sampling tool (qualitative).</description>
        </group>
        <group group_id="B2">
          <title>Culturally-targeted Fear Appeal Message HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message: Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.</description>
        </group>
        <group group_id="B3">
          <title>Fear Appeal Message HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Fear Appeal Message: Participants will receive fear appeal messages (only) in a graphically designed kit.</description>
        </group>
        <group group_id="B4">
          <title>HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="0"/>
            <count group_id="B4" value="89"/>
            <count group_id="B5" value="173"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.40" spread="9.442"/>
                    <measurement group_id="B2" value="45.01" spread="9.099"/>
                    <measurement group_id="B4" value="41.09" spread="10.222"/>
                    <measurement group_id="B5" value="44.50" spread="9.587"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="89"/>
                    <measurement group_id="B5" value="173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="89"/>
                    <measurement group_id="B5" value="173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="89"/>
                    <measurement group_id="B5" value="173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior pap test experience</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B4" value="72"/>
                    <measurement group_id="B5" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants That Used and Returned Their Self-sampler Kit.</title>
        <description>Number of participants that used and returned their self-sampler kit was evaluated.</description>
        <time_frame>2 weeks</time_frame>
        <population>Data was not collected for the fear appeal message HPV self-sampling condition due to lack of funding.</population>
        <group_list>
          <group group_id="O1">
            <title>Culturally-targeted Fear Appeal Message HPV Self-sampling Kit</title>
            <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message: Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.</description>
          </group>
          <group group_id="O2">
            <title>Fear Appeal Message HPV Self-sampling Kit</title>
            <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Fear Appeal Message: Participants will receive fear appeal messages (only) in a graphically designed kit.</description>
          </group>
          <group group_id="O3">
            <title>HPV Self-sampling Kit</title>
            <description>Participants will receive an HPV self-sampling kit to screen for HPV
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.</description>
          </group>
          <group group_id="O4">
            <title>HPV Self-sampling Kit + Interview</title>
            <description>Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interview: Participants will be interviewed about experiences using the self-sampling tool (qualitative).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Used and Returned Their Self-sampler Kit.</title>
          <description>Number of participants that used and returned their self-sampler kit was evaluated.</description>
          <population>Data was not collected for the fear appeal message HPV self-sampling condition due to lack of funding.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="89"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O3" value="83"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>HPV Self-sampling Kit + Interview</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interview: Participants will be interviewed about experiences using the self-sampling tool (qualitative).</description>
        </group>
        <group group_id="E2">
          <title>Culturally-targeted Fear Appeal Message HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message: Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.</description>
        </group>
        <group group_id="E3">
          <title>HPV Self-sampling Kit</title>
          <description>Participants will receive an HPV self-sampling kit to screen for HPV
HPV self-sampling kit: The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Susan Morgan</name_or_title>
      <organization>University of Miami</organization>
      <phone>7654094919</phone>
      <email>semorgan@miami.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

